You have full text access to this OnlineOpen article

Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis

  1. Eiichi Tokuda1,
  2. Eriko Okawa1,
  3. Shin-ichi Ono1,2

Article first published online: 27 JUL 2009

DOI: 10.1111/j.1471-4159.2009.06310.x

Issue

Journal of Neurochemistry

Journal of Neurochemistry

Volume 111, Issue 1, pages 181–191, October 2009

Additional Information

How to Cite

Tokuda, E., Okawa, E. and Ono, S.-i. (2009), Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis. Journal of Neurochemistry, 111: 181–191. doi: 10.1111/j.1471-4159.2009.06310.x

Author Information

  1. 1

    Research Unit of Clinical Pharmacy, College of Pharmacy, Nihon University, Tokyo, Japan

  2. 2

    Division of Neurology, Akiru Municipal Medical Center, Tokyo, Japan

*Address correspondence and reprint requests to Shin-ichi Ono, MD, PhD, FACP, 7-7-1, Narashinodai, Funabashi, Chiba, 274-8555, Japan. E-mail: ono.shinichi@nihon-u.ac.jp

Publication History

  1. Issue published online: 14 SEP 2009
  2. Article first published online: 27 JUL 2009
  3. Received May 15, 2009; revised manuscript received July 10, 2009; accepted July 21, 2009.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (781K)

References

  • Ahtoniemi T., Goldsteins G., Keksa-Goldsteine V., Malm T., Kanninen K., Salminen A. and Koistinaho J. (2007) Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis. Mol. Pharmacol. 71, 30–37.
  • Andreassen O. A., Dedeoglu A., Friedlich A., Ferrante K. L., Hughes D., Szabo C. and Beal M. F. (2001) Effects of an inhibitor of poly (ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp. Neurol. 168, 419–424.
  • Bartnikas T. B. and Gitlin J. D. (2001) How to make a metalloprotein. Nat. Struct. Biol. 8, 733–734.
  • Beckman J. S., Carson M., Smith C. D. and Koppenol W. H. (1993) ALS, SOD and peroxynitrite. Nature 364, 584.
  • Beers D. R., Henkel J. S., Xiao Q., Zhao W., Wang J., Yen A. A., Siklos L., McKercher S. R. and Appel S. H. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 103, 16021–16026.
  • Boillée S., Yamanaka K., Lobsiger C. S., Copeland N. G., Jenkins N. A., Kassiotis G., Kollias G. and Cleveland D. W. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389–1392.
  • Brewer G. J. (2005) Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discov. Today 16, 1103–1109.
  • Bruijn L. I., Miller T. M. and Cleveland D. W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723–749.
  • Clement A. M., Nguyen M. D., Roberts E. A. et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113–117.
  • Corson L. B., Strain J. J., Culotta V. C. and Cleveland D. W. (1998) Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl Acad. Sci. USA 95, 6361–6366.
  • Domzal T. and Radzikowska B. (1983) Ceruloplasmin and copper in the serum of patients with amyotrophic lateral sclerosis (ALS). Neurol. Neurochir. Pol. 17, 343–346.
  • Gabbianelli R., Ferri A., Rotilio G. and Carrì M. T. (1999) Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis. J. Neurochem. 73, 1175–1180.
    Direct Link:
  • Gellein K., Garruto R. M., Syversen T., Sjøbakk T. E. and Flaten T. P. (2003) Concentrations of Cd, Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue in amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam determined by high-resolution ICP-MS. Biol. Trace Elem. Res. 96, 39–60.
  • Gurney M. E., Pu H., Chiu A. Y. et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772–1775.
  • Harraz M. M., Marden J. J., Zhou W. et al. (2008) SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J. Clin. Invest. 118, 659–670.
  • Hart P. J. (2006) Pathogenic superoxide dismutase structure, folding, aggregation, and turnover. Curr. Opin. Chem. Biol. 10, 131–138.
  • Hottinger A. F., Fine E. G., Gurney M. E., Zurn A. D. and Aebischer P. (1997) The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur. J. Neurosci. 9, 1548–1551.
    Direct Link:
  • Jonsson P. A., Graffmo K. S., Andersen P. M., Brännström T., Lindberg M., Oliveberg M. and Marklund S. L. (2006) Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 129, 451–464.
  • Jung C., Higgins C. M. J. and Xu Z. (2002) Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J. Neurochem. 83, 535–545.
    Direct Link:
  • Kako K., Takehara A., Arai H. et al. (2004) A selective requirement for copper-dependent activation of cytochrome c oxidase by Cox17p. Biochem. Biophys. Res. Commun. 324, 1379–1385.
  • Kelner G. S., Lee M. H., Clark M. E. et al. (2000) The copper transport protein Atox1 promotes neuronal survival. J. Biol. Chem. 275, 580–584.
  • Kiaei M., Bush A. I., Morrison B. M., Morrison J. H., Cherny R. A., Volitakis I., Beal M. F. and Gordon J. W. (2004) Genetically decreased spinal cord copper concentration prolongs life in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 24, 7945–7950.
  • Kikuchi H., Almer G., Yamashita S., Guégan C., Nagai M., Xu Z., Sosunov A. A., McKhann G. M. and Przedborski S. (2006) Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl Acad. Sci. USA 103, 6025–6030.
  • Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in CNS. Trends Neurosci. 19, 312–318.
  • Kuo Y. M., Zhou B., Cosco D. and Gitschier J. (2001) The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc. Natl Acad. Sci. USA 98, 6836–6841.
  • Larin D., Mekios C., Das K., Ross B., Yang A. S. and Gilliam T. C. (1999) Characterization of the interaction between the Wilson and Menkes disease proteins and cytoplasmic copper chaperone, HAH1p. J. Biol. Chem. 274, 28497–28504.
  • Lee J., Prohaska J. R. and Thiele D. J. (2001) Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc. Natl Acad. Sci. USA 98, 6842–6847.
  • Li M., Ona V. O., Guégan C. et al. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335–339.
  • Li Q. X., Mok S. S., Laughton K. M., McLean C. A., Volitakis I., Cherny R. A., Cheung N. S., White A. R. and Masters C. L. (2006) Overexpression of Aβ is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model. Aging Cell 5, 153–165.
    Direct Link:
  • Lindquist R. R. (1969) Studies on the pathogenesis of hepatolenticular degeneration II. Cytochemical methods for the localization of copper. Arch. Pathol. 87, 370–379.
  • Lippard S. J. (1999) Free copper ions in the cell? Science 284, 748–749.
  • Lutsenko S., Petrukhin K., Cooper M. J., Gilliam C. T. and Kaplan J. H. (1997) N-terminal domains of human copper-transporting adenosine triphosphases (the Wilson’s and Menkes disease proteins) bind copper selectivity in vivo and in vitro with stoichiometry of one copper per metal-binding repeat. J. Biol. Chem. 272, 18939–18944.
  • Nagano S., Fujii Y., Yamamoto T., Taniyama M., Fukada K., Yanagihara T. and Sakoda S. (2003) The efficacy of trientine or ascorbate alone compared to that of the combined treatment with these two agents in familial amyotrophic lateral sclerosis model mice. Exp. Neurol. 179, 176–180.
  • Ohgami R. S., Campagna D. R., McDonald A. and Fleming M. D. (2006) The steap proteins are metalloreductases. Blood 108, 1388–1394.
  • Olsen M. K., Roberds S. L., Ellerbrock B. R., Fleck T. J., McKinley D. K. and Gurney M. E. (2001) Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann. Neurol. 50, 730–740.
    Direct Link:
  • Pasinelli P., Houseweart M. K., Brown R. H. Jr and Cleveland D. W. (2000) Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97, 13901–13906.
  • Petris M. J., Mercer J. F. B., Culvenor J. G., Lockhart P., Gleeson P. A. and Camakaris J. (1996) Ligand-regulated transport of the Menkes copper p-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J. 15, 6084–6095.
  • Petris M. J., Camakaris J., Greenough M., LaFontaine S. and Mercer J. F. K. (1998) A C-terminal di-leucine is required for localization of the Menkes protein in the trans-Golgi network. Hum. Mol. Genet. 7, 2063–2071.
  • Rakhit R., Cunningham P., Furtos-Matei A., Dahan S., Qi X. F., Crow J. P., Cashman N. R., Kondejewski L. H. and Chakrabartty A. (2002) Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 277, 47551–47556.
  • Reaume A. G., Elliott J. L., Hoffman E. K. et al. (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13, 43–47.
  • Rosen D. R., Siddique T., Patterson D. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59–62.
  • Rossi D., Brambilla L., Valori C. F., Roncoroni C., Crugnola A., Yokota T., Bredesen D. E. and Volterra A. (2008) Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 15, 1691–1700.
  • Rowland L. P. and Shneider N. A. (2001) Amyotrophic lateral sclerosis. N. Engl. J. Med. 344, 1688–1700.
  • Shaw B. F. and Valentine J. S. (2006) How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem. Sci. 32, 78–85.
  • Son M., Puttaparthi K., Kawamata H., Rajendran B., Boyer P. J., Manfredi G. and Elliott J. L. (2007) Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc. Natl Acad. Sci. USA 104, 6072–6077.
  • Subramaniam J. R., Lyons W. E., Liu J., Bartnikas T. B., Rothstein J., Price D. L., Cleveland D. W., Gitlin J. D. and Wong P. C. (2002) Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5, 301–307.
  • Takahashi Y., Kako K., Kashiwabara S. et al. (2002) Mammalian copper chaperone Cox17p has an essential role in activation of cytochrome c oxidase and embryonic development. Mol. Cell. Biol. 22, 7614–7621.
  • Tokuda E., Ono S. I., Ishige K., Naganuma A., Ito Y. and Suzuki T. (2007) Metallothionein proteins expression, copper and zinc concentrations and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis. Toxicology 229, 33–41.
  • Tokuda E., Ono S. I., Ishige K., Watanabe S., Okawa E., Ito Y. and Suzuki T. (2008) Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis. Exp. Neurol. 213, 122–128.
  • Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R. and Julien J. P. (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9, 108–118.
  • Urushitani M., Ezzi S. A., Matsuo A., Tooyama I. and Julien J. P. (2008) The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J. 22, 2476–2487.
  • Wang J., Slunt H., Gonzales V., Fromholt D., Coonfield M., Copeland N. G., Jenkins N. A. and Borchelt D. R. (2003) Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum. Mol. Genet. 12, 2753–2764.
  • Watanabe K., Miyakawa O. and Kobayashi M. (2001) New method for quantitative mapping of metallic elements in tissue section by electron probe microanalyser with wavelength dispersive spectrometers. J. Electron Microsc. 50, 77–82.
  • Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S. and Bredesen D. E. (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515–518.
  • Wong P. C., Waggoner D., Subramaniam J. R., Tessarollo L., Bartnikas T. B., Culotta V. C., Price D. L., Rothstein J. and Gitlin J. D. (2000) Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl Acad. Sci. USA 97, 2886–2891.
  • Yamanaka K., Chun S. J., Boillée S., Fujimori-Tonou N., Yamashita H., Gutmann D. H., Takahashi R., Misawa H. and Cleveland D. W. (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251–253.
View Full Article with Supporting Information (HTML) Get PDF (781K)